Journal
/
/
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
JoVE Journal
Biologia do Desenvolvimento
É necessária uma assinatura da JoVE para visualizar este conteúdo.  Faça login ou comece sua avaliação gratuita.
JoVE Journal Biologia do Desenvolvimento
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
DOI:

06:39 min

October 03, 2018

, , ,

Capítulos

  • 00:04Título
  • 00:39Recipient Mouse Preparation and Bone Marrow Nucleated Cell (BMNC) Harvest
  • 02:25BMNC Fluorescence-activated Cell Sorting (FACS) and Hematopoietic Stem Cell Transplantation (HSCT)
  • 04:52Results: Representative HSCT Analyses
  • 06:08Conclusion

Summary

Tadução automática

We describe the use of hematopoietic stem cell transplantation (HSCT) to assess the malignant potential of genetically engineered hematopoietic cells. HSCT is useful for evaluating various malignant hematopoietic cells in vivo as well as generating a large cohort of mice with myelodysplastic syndromes (MDS) or leukemia to evaluate novel therapies.

Vídeos Relacionados

Read Article